PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Microbiology, Radboud University Medical Center, and Radboudumc-CWZ Center of Expertise for Mycology, Nijmegen, the Netherlands.\', \'Department of Intensive Care, Gelderse Vallei Hospital, Ede, the Netherlands.\', \'Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands.\', \'Microvida Laboratory for Microbiology, Amphia Hospital, Breda, the Netherlands.\', \'Department of Intensive Care, Amphia Hospital, Breda, the Netherlands.\', \'Department of Infectious Diseases, Amsterdam University Medical Center, Amsterdam, the Netherlands.\', \'Department of Intensive Care, Leiden University Medical Center, Leiden, the Netherlands.\', \'Department of Medical Microbiology, Gelderse Vallei Hospital, Ede, the Netherlands.\', \'Center for Infectious Disease Research, Diagnostics and Laboratory Surveillance National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2807/1560-7917.ES.2021.26.23.2100510
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 34114540
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all